Interleukin-36 as a Novel Therapeutic Target for Atherosclerosis Pathogenesis: Curr. Probl. Cardiol., 2025 Review Highlights Aashi verma6 March 2026 9:00 PM ISTA recent review identifies interleukin-36 (IL-36) as a transformative driver of vascular inflammation, revealing that serum concentrations in patients...
150 minutes of flexible Weekly Exercise Patterns Lower CV Risk in Overweight Adults: Study Medha Baranwal6 March 2026 8:45 PM ISTChina: Researchers have found in a new study that among adults with overweight or obesity, achieving at least 150 minutes of moderate-to-vigorous...
Semaglutide may Improve Metabolic Control in Latent Autoimmune Diabetes in Adults, Finds Study Medha Baranwal6 March 2026 11:00 AM ISTItaly: A retrospective study published in the Journal of Clinical Endocrinology & Metabolism has found that patients with latent autoimmune...
T2DM and Obesity Additively Increase Platelet Hyperreactivity and CV Risk: Study Jacinthlyn Sylvia6 March 2026 9:30 AM ISTA new study published in the journal of Thrombosis Research found that the combined presence of type 2 diabetes mellitus (T2DM) and obesity exerts a...
Pregnancy Outcomes in Long-Chain Fatty Acid Oxidation Disorders are Generally Favorable: Study Finds Medha Baranwal5 March 2026 8:00 PM ISTGermany: Researchers have found in a new study that pregnancy outcomes in patients with long-chain fatty acid oxidation disorders (lcFAOD) are...
GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death: Study Dr. Kamal Kant Kohli5 March 2026 9:30 AM ISTGlucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of...
Orforglipron Found Superior to Oral Semaglutide in HbA1c and Weight Reduction in ACHIEVE-3 trial Medha Baranwal5 March 2026 8:00 AM ISTUSA: In the ACHIEVE-3 trial published in The Lancet, once-daily orforglipron demonstrated greater reductions in HbA1c and body weight compared with...
Type 1 Diabetes Linked to Fourfold Higher Risk of Bladder Cancer: Meta-Analysis Shows Medha Baranwal4 March 2026 9:00 AM ISTUSA: A recent systematic review and meta-analysis published in Diabetes Research and Clinical Practice has unveiled compelling evidence that type 1...
GLP-1 Drugs Linked to Modest Rise in Fracture Risk in Older Adults with Type 2 Diabetes: Study Medha Baranwal4 March 2026 8:45 AM ISTIsrael: Glucagon-like peptide-1 receptor agonists (GLP-1RAs), widely used for their glycemic and cardiovascular benefits in type 2 diabetes, may be...
Oral Semaglutide Cuts Heart Failure Events in Diabetes Patients With Prior HF: SOUL Trial Analysis Medha Baranwal3 March 2026 9:45 AM ISTUSA: Oral semaglutide may lower the risk of heart failure-related events in people with type 2 diabetes who already have heart failure, without...
Weight loss drug linked to lower risk of eye disease in patients with diabetes, finds study Dr. Kamal Kant Kohli2 March 2026 11:30 AM ISTThe popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading...
FDA Approves Oral Desmopressin for Central Diabetes Insipidus Dr. Kamal Kant Kohli1 March 2026 8:30 PM ISTThe U.S. Food and Drug Administration has approved desmopressin acetate oral solution (Desmoda) for the treatment of central diabetes insipidus in...
